Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
Nguyen, G. N., George, L. A., Siner, J. I., Davidson, R. J., Zander, C. B., Zheng, X. L., Arruda, V. R., Camire, R. M., Sabatino, D. E.
Published in Journal of thrombosis and haemostasis (01.01.2017)
Published in Journal of thrombosis and haemostasis (01.01.2017)
Get full text
Journal Article
Apoptotic effects of platelet factor VIII on megakaryopoiesis: implications for a modified human FVIII for platelet‐based gene therapy
Greene, T. K., Lyde, R. B., Bailey, S. C., Lambert, M. P., Zhai, L., Sabatino, D. E., Camire, R. M., Arruda, V. R., Poncz, M.
Published in Journal of thrombosis and haemostasis (01.12.2014)
Published in Journal of thrombosis and haemostasis (01.12.2014)
Get full text
Journal Article
SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
Sabatino, D.E., Lange, A.M., Sarkar, R., Dillow, A.M., Nichols, T.C., Arruda, V.R., Kazazian, H.H.
Published in Journal of thrombosis and haemostasis (01.07.2007)
Published in Journal of thrombosis and haemostasis (01.07.2007)
Get full text
Journal Article